标题
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 9, Issue 9, Pages 513-523
出版商
Springer Nature
发表日期
2013-06-18
DOI
10.1038/nrrheum.2013.91
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab
- (2012) Hennie G Raterman et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis
- (2012) Claire Immediato Daïen et al. ANNALS OF THE RHEUMATIC DISEASES
- Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis
- (2012) Christina Charles-Schoeman et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
- (2012) Juan Antonio Avina-Zubieta et al. ANNALS OF THE RHEUMATIC DISEASES
- Proteomic profiling following immunoaffinity capture of high-density lipoprotein: Association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis
- (2012) Junji Watanabe et al. ARTHRITIS AND RHEUMATISM
- Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors
- (2012) Misato Hashizume et al. CYTOKINE
- Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
- (2012) Philip J. Barter et al. JOURNAL OF LIPID RESEARCH
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
- (2012) Elke Arts et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
- (2011) Yusuf Yazici et al. ANNALS OF THE RHEUMATIC DISEASES
- Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
- (2011) E. Myasoedova et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
- (2011) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- The Effect of TNF-alpha Blocking Therapy on Lipid Levels in Rheumatoid Arthritis: A Meta-Analysis
- (2011) Alper M. van Sijl et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
- (2010) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better
- (2010) M. J. L. Peters et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Lipoprotein Subclasses Determined by Nuclear Magnetic Resonance Spectroscopy and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis
- (2010) C. P. CHUNG et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)
- (2010) Hisashi Yamanaka et al. Modern Rheumatology
- Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients
- (2010) Stephanie J. Morris et al. ARTHRITIS CARE & RESEARCH
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Total cholesterol and LDL levels decrease before rheumatoid arthritis
- (2009) E. Myasoedova et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis
- (2009) I. C. van Eijk et al. ARTHRITIS AND RHEUMATISM
- Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis
- (2009) György Kerekes et al. CLINICAL RHEUMATOLOGY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies
- (2009) C. Meune et al. RHEUMATOLOGY
- Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients
- (2008) C Popa et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages
- (2008) Allison B. Reiss et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now